After a thorough and comprehensive review of proposals received from suppliers of viral marker testing platforms and assays, CTS has decided to convert to the Ortho VERSEIA Integrated Processor (VIP) viral marker testing platform and associated assays in January 2021. An exact conversion date will be provided when available. We are confident that the VERSIA system will allow us to continue delivering on our commitment to support our clients in their life-saving mission.
Read all about it on the Communication page by clicking the this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
Reminder: On Wednesday August 15, 2018 at 11:00AM PDT, we will be hosting a webinar regarding the ch...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
In July, all 5 CTS laboratories will convert from the current Grifols Ultrio Plus NAT triplex assay ...